Solving the Problem of Insolubility: Part III
March 3, 2026
Exploring new applications for KinetiSol and the evolving role of CDMOs in bringing the next generation of complex molecules to patients
4 min read
False
Advertisement
Top Stories
Browse By Topic
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
Voices in the Community
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
FOYA: Celebrating Innovation in Pharma Facilities
We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.
Latest News
All the latest Medicine Maker articles.
Human-Relevant Discovery: iPSC Models and the Future of Rare Disease R&D
February 25, 2026
A Q&A with iXCells Biotechnologies CEO, Steve Smith
8 min read
Syngene and Johns Hopkins Partner to Advance Early-Stage Drug Discovery
February 25, 2026
Collaboration anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research
1 min read
Solving the Problem of Insolubility: Part II
February 24, 2026
KinetiSol’s solvent-free mixing process turns “brick dust” drugs into stable amorphous dispersions
5 min read
Cirena Launches High-Purity Long RNA to Accelerate CRISPR and Genome-Editing Research
February 23, 2026
New technology enables faster design cycles and improved editing precision
1 min read
Building an Integrated Discovery Engine
February 23, 2026
An Interview with Adam Davenport, CSO, Concept Life Sciences
4 min read
A Practical Approach to Early-Phase CMC
February 20, 2026
Integrated, risk-based chemistry, manufacturing and controls strategies support early-phase development, writes Richard Chubb
6 min read
A Simpler, Smarter CHO Strategy for High-Quality Bispecifics
February 19, 2026
Here’s how next-generation cell line and manufacturing methods can boost productivity, improve purity, and remove bottlenecks in bispecific antibody development
12 min read
The Importance of AI in Genome Sequencing
February 19, 2026
Scaling genomics with AI and automation is one thing, but building the infrastructure to support it is what will really drive innovation in the space
3 min read
Cell and Gene Therapy Catapult Establishes Technology Advisory Board
February 19, 2026
New board will identify opportunities for the advanced therapies sector to deploy and benefit from innovations
2 min read
Building Better Oral Suspensions for Pediatric & Real-World Use
February 18, 2026
Greg Thomas, Kiel Laboratories’ Vice President of R&D, discusses oral suspensions, excipients, and patient-centered formulation
4 min read
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.